CDER Therapeutic Biologic Billable List Mmm yy

First Page		Document Content
Ustekinumab Biologic License Application Food and Drug Administration BLA		CDER Therapeutic Biologic Billable List Mmm yy Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 284,82 KB Share Document on Facebook

	www.medscape.com/viewarticle/864011_print www.medscape.com DocID: 1pzpz - View Document
	Ixekizumab for moderate to severe chronic plaque psoriasis DocID: 1gyoS - View Document
	438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- DocID: 1fNC6 - View Document
	STELARATM (ustekinumab) STN: BLHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA™ safely and effectively. See full prescribing information for STE DocID: 1ceTm - View Document
	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement DocID: 1a6Du - View Document